Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Post-Marketing Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

NCT02562742 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02562742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02562742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Post-Marketing Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
November 12, 2015
Completion date
June 12, 2017
Enrollment
554 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c